Larson Financial Group’s Merck MRK Stock Holding History

Larson Financial Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64K	Buy	+200	New	+$23.4K	﹤0.01%	3177

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Larson Financial Group's MRK Position: Q2 2026 in Review

Larson Financial Group increased its Merck (MRK) stake by 7.1% in Q2 2026, buying an estimated $495K and bringing the position to 63,932 shares worth $8.22M. The position accounts for 0.22% of the portfolio, ranked #80.

Larson Financial Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Larson Financial Group held 63,932 shares of Merck worth $8.22M as of Q2 2026.
Larson Financial Group bought 4,225 Merck shares in Q2 2026, an estimated $495K.
Merck made up 0.22% of Larson Financial Group's portfolio in Q2 2026, its #80 holding.
Larson Financial Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.